Showing 721-730 of 3223 results for "".
Could it be KC (KERATOCONUS)?
https://modernod.com/mod-issues/supplements-inserts/could-it-be-kc-keratoconus-kc-file-2-autorefractor-clues-that-were-ignored/38795/KC File #2: Autorefractor Clues That Were IgnoredBreaking Down Meibomian Gland Dysfunction
https://modernod.com/topics/ocular-surface/breaking-down-meibomian-gland-dysfunction/38748/Different clinical manifestations require different treatment approaches for the best results.Glaucoma Suspect or Glaucoma Patient?
https://modernod.com/topics/glaucoma/glaucoma-suspect-or-glaucoma-patient/39063/Consider each patient’s risk for loss of functional vision.Papilledema
https://modernod.com/topics/retina/papilledema/38131/The Challenges of Benzalkonium Chloride in Glaucoma Care
https://modernod.com/topics/glaucoma/the-challenges-of-benzalkonium-chloride-in-glaucoma-care/54304/A look at the cytotoxic effects on the ocular surface, and the potential of preservative-free medications.A Complex Case of Treatment-Resistant Pediatric Neurotrophic Keratitis
https://modernod.com/mod-issues/novemberdecember-2023-supplement/a-complex-case-of-treatment-resistant-pediatric-neurotrophic-keratitis/38709/Monitoring Myopia Progression With the Myopia Master®
https://modernod.com/mod-issues/supplements-inserts/monitoring-myopia-progression-with-the-myopia-master/38640/Discussing Refractive Options With Patients Who Have High Myopia
https://modernod.com/mod-issues/2022-jan-feb/discussing-refractive-options-with-patients-who-have-high-myopia/39125/When a phakic IOL is the best option, it pays to be ready to identify candidates and provide collaborative care.The Role of Artificial Intelligence in Detecting Diabetic Retinopathy
https://modernod.com/mod-issues/2019-nov-dec/the-role-of-artificial-intelligence-in-detecting-diabetic-retinopathy/39094/A look at the technology’s potential to diagnose disease earlier and help to prevent blindness.What’s New in Dry Eye Management?
https://modernod.com/topics/ocular-surface/whats-new-in-dry-eye-management/38765/A look at our growing list of options.